Increased breath naphthalene in children with asthma and wheeze of the All Age Asthma Cohort (ALLIANCE).
P Shahrokny, N Maison, L Riemann...
https://pubmed.ncbi.nlm.nih.gov/37604132/Actively Recruiting
Led by LMU Klinikum · Updated on 2024-08-28
1500
Participants Needed
5
Research Sites
N/A
Total Duration
Researchers are investigating asthma and wheeze in children and how different forms and progressions of these conditions develop. The study aims to understand the underlying mechanisms and identify specific molecular patterns linked to various asthma and wheeze types. This may help create personalized treatments and early prevention methods. The research is part of the German Centre for Lung Research DZL and focuses on childhood asthma, including those who are newly diagnosed or already receiving controller therapy, as well as healthy children for comparison. Children with new or existing wheeze or asthma, including those not yet treated with steroids or leukotriene receptor antagonists, are being recruited. Healthy children matched by age and sex are also included as controls. Participants undergo regular assessments, including lung function tests and collection of biological samples such as blood, nasal secretions, and sputum. These procedures are repeated over time to monitor disease progression and molecular changes. The study uses standardized methods and quality controls across multiple sites. Participants will have detailed clinical exams, questionnaires, lung function tests, and provide various biological samples at baseline and during yearly follow-ups for up to two years. Researchers will track asthma prevalence, wheeze episodes, lung function, biomarkers like exhaled nitric oxide, and frequency of flare-ups. Data management and laboratory teams analyze the collected information using advanced computational techniques to identify patterns and potential targets for personalized care. The study aims to minimize missing data and apply statistical methods to ensure robust findings over the study duration.
CONDITIONS
Pediatric Arm of DZL All Age Asthma Cohort
E
Esther Zeitlmann, Diplom
B
Bianca Schaub, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
LMU Klinikum
Lead Sponsor
German Federal Ministry of Education and Research
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo comprehensive clinical assessment including questionnaires, physical examination, lung function tests, and collection of biomaterials to establish asthma or wheeze phenotypes.
1 baseline visit (in-person)
Duration - Up to 2 years
Participants with new-onset or controller therapy wheeze/asthma are followed-up regularly to assess asthma trajectories, exacerbations, and biomarker changes using the same clinical tools and biomaterial collections as at baseline. Healthy controls do not undergo follow-up.
Yearly visits for up to 2 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Have more questions? Get in touch with our team for quick support
P Shahrokny, N Maison, L Riemann...
https://pubmed.ncbi.nlm.nih.gov/37604132/Constanze A Jakwerth, Markus Weckmann, Sabina Illi...
https://pubmed.ncbi.nlm.nih.gov/38064241/Markus Weckmann, Thomas Bahmer, Jannie Marie Sand...
https://pubmed.ncbi.nlm.nih.gov/34326188/Nicole Maison, Jimmy Omony, Sabina Illi...
https://pubmed.ncbi.nlm.nih.gov/35210326/Lena Lagally, Lena Ullemeyer, Jimmy Omony...
https://pubmed.ncbi.nlm.nih.gov/42509549/Oliver Fuchs, Thomas Bahmer, Markus Weckmann...
https://pubmed.ncbi.nlm.nih.gov/30126401/Chrysanthi Skevaki, Pavel Tafo, Kathrin Eiringhaus...
https://pubmed.ncbi.nlm.nih.gov/34128558/LMU Klinikum
Lead Sponsor
German Federal Ministry of Education and Research
Collaborating Sponsor